Red blood cell transfusion in critically ill patients with traumatic brain injury: an international survey of physicians' attitudes.

Transfusion d’érythrocytes chez les patients en état critique atteints de traumatisme cérébral : une enquête de pratique internationale des médecins.

Journal

Canadian journal of anaesthesia = Journal canadien d'anesthesie
ISSN: 1496-8975
Titre abrégé: Can J Anaesth
Pays: United States
ID NLM: 8701709

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 19 06 2018
accepted: 18 02 2019
revised: 17 02 2019
pubmed: 24 4 2019
medline: 21 10 2020
entrez: 24 4 2019
Statut: ppublish

Résumé

Restrictive transfusion strategies have been advocated in critically ill patients. Nevertheless, considerable uncertainty exists regarding optimal transfusion thresholds in traumatic brain injury (TBI) patients because the injured brain is susceptible to hypoxemic damage. We aimed to identify the determinants of red blood cell (RBC) transfusion and the perceived optimal transfusion thresholds in adult patients with moderate-to-severe TBI. We conducted an electronic, self-administered survey targeting critical care specialists and neurosurgeons from Canada, Australia, and the United Kingdom caring for TBI patients. The questionnaire was initially developed by a panel of experts using a structured process (domains/items generation and reduction). The questionnaire was validated for clinical sensibility, reliability, and content. The response rate was 28.7% (218/760). When presented with the hypothetical scenario of a young adult TBI patient, a wide range of transfusion practices was observed, with 47 (95% confidence interval [CI], 41 to 54)% favouring RBC transfusion at a hemoglobin level of ≤ 70 g·L In our survey about critically ill TBI patients, transfusion practice was found to be mainly influenced by the acuity of care, patient characteristics, and neuro-monitoring. Clinical equipoise regarding optimal transfusion strategy is believed to be mainly attributed to the lack of clear clinical evidence and guidelines. Appropriate randomized-controlled trials are required to determine the optimal transfusion strategies in TBI patients.

Identifiants

pubmed: 31012052
doi: 10.1007/s12630-019-01369-w
pii: 10.1007/s12630-019-01369-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1038-1048

Subventions

Organisme : CIHR
ID : 354039
Pays : Canada

Auteurs

Paule Lessard Bonaventure (P)

CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology - Emergency - Critical Care Medicine, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), 1401, 18e rue, Québec City, QC, G1J 1Z4, Canada.
Department of Surgery, Division of Neurosurgery, Université Laval, Québec City, QC, Canada.

Francois Lauzier (F)

CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology - Emergency - Critical Care Medicine, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), 1401, 18e rue, Québec City, QC, G1J 1Z4, Canada.
Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec City, QC, Canada.
Department of Medicine, Université Laval, Québec City, QC, Canada.

Ryan Zarychanski (R)

Department of Internal Medicine, Sections of Critical Care Medicine, of Haematology and of Medical Oncology, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.

Amélie Boutin (A)

CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology - Emergency - Critical Care Medicine, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), 1401, 18e rue, Québec City, QC, G1J 1Z4, Canada.

Michèle Shemilt (M)

CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology - Emergency - Critical Care Medicine, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), 1401, 18e rue, Québec City, QC, G1J 1Z4, Canada.

Manoj Saxena (M)

The George Institute for Global Health, Sydney, Australia.

Parjam Zolfagari (P)

Neurocritical Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals Trust, Cambridge University, Cambridge, UK.

Donald Griesdale (D)

Division of Critical Care Medicine, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

David K Menon (DK)

Neurocritical Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals Trust, Cambridge University, Cambridge, UK.

Simon Stanworth (S)

National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, Oxford University Hospitals and the University of Oxford, Oxford, UK.

Shane English (S)

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Department of Medicine (Critical Care), University of Ottawa, Ottawa, ON, Canada.

Michaël Chassé (M)

CHUM Research Center, Université de Montréal, Montréal, QC, Canada.

Dean A Fergusson (DA)

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Lynne Moore (L)

CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology - Emergency - Critical Care Medicine, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), 1401, 18e rue, Québec City, QC, G1J 1Z4, Canada.
Department of Preventive and Social Medicine, Université Laval, Québec City, QC, Canada.

Andreas Kramer (A)

Department of Critical Care Medicine, Foothills Medical Center, Calgary, AB, Canada.

Amélie Robitaille (A)

CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology - Emergency - Critical Care Medicine, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), 1401, 18e rue, Québec City, QC, G1J 1Z4, Canada.

John Myburgh (J)

The George Institute for Global Health, Sydney, Australia.

Jamie Cooper (J)

The George Institute for Global Health, Sydney, Australia.
The Alfred Hospital, Melbourne, Australia.

Peter Hutchinson (P)

Neurocritical Care Unit, Addenbrooke's Hospital, Cambridge University Hospitals Trust, Cambridge University, Cambridge, UK.

Alexis F Turgeon (AF)

CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Traumatology - Emergency - Critical Care Medicine, CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), 1401, 18e rue, Québec City, QC, G1J 1Z4, Canada. alexis.turgeon@fmed.ulaval.ca.
Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec City, QC, Canada. alexis.turgeon@fmed.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH